RBR-2xd6dkj招募中4 期
Phase IV Clinical Efficacy Study, randomized, double-blind, placebo controlled MMR Vaccine (against measles, mumps and rubella) in the Prevention or Reduction of Severety of COVID-19 in Men and Women Healthcare Workers 18 to 60 years old
niversidade Federal de Santa Catarina0 个研究点开始时间: 2021年2月12日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 60Y（—）
入选标准
- •Men and women from 18 to 60 years old (inclusive) in Visit 1; volunteers, who in the opinion researchers, are able to fulfill the requirements of the Protocol (carry out all visits, fill in the post-vaccination diary and no intention of moving to another city); obtaining the Term of Free and Informed Consent (FICT) signed, after reading and discussing it, before taking any procedure
排除标准
- •Women who are pregnant or wishing to become pregnant during the study period; women who are breastfeeding; subjects with immune system deficiency (HIV or who are performing or performed in the last 90 days treatments such as chemotherapy, radiation therapy, high doses of corticosteroids (greater than 20 mg / day for more than 14 days) or immunosuppressants); receptors of immunoglobulins or blood products in the last 180 days;
- •people with decompensated autoimmune diseases, such as systemic lupus erythematosus, sclerosis multiple, Guillain-Barré syndrome, myasthenia gravis, scleroderma; have received an attenuated vaccine in the last 30 days or inactivated in the last 15 days; fever greater than 37.8 degrees Celsius and / or inflammatory / infectious oropharyngeal process; previous history of positive test for SARS-CoV-2 by PCR or Rapid Test or serology; Covid-19 suspected clinical history and / or physical examination, such as fever (greater than 38 degrees Celsius), odynophagia, cough, dyspnoea and anosmia; anaphylactic-type hypersensitivity to any component of the vaccine; any other clinical condition that, at the discretion of the investigator, may interfere with the results of the study or may bring some risk to the study volunteer; it's be participating or wish to participate in another study that is evaluating the use of another vaccine.
研究者
相似试验
进行中（未招募）
不适用
Study about the high flow and conventional oxigen therapy in patients with severe acute respiratory failure.EUCTR2012-001671-36-ESFundación para la Investigación Biomédica
进行中（未招募）
1 期
Clinical phase IV study assessing the efficacy and safety of the medicinal product Groprinosin in treatment of recurrent airway inflammation in children with impaired cellular immunity and diagnosed or undiagnosed allergic diseaseRecurrent airway inflammation in children with impaired cellular immunity.EUCTR2013-003303-18-PLGedeon Richter Polska Sp. z o. o.
进行中（未招募）
不适用
Clinical trial to evaluate the immune response and safety of a combined Tdap vaccine(Boostrix, GSK) and antipapilloma human virus vaccine (Gardasil) vaccine when administered with the meningococcal conjugate ACWY Novartis or placebo.Menveo is indicated for active immunization of adolescents (from 11 years of age) and adults at risk of exposure to Neisseria meningitidis groups A, C, W135 and Y, to prevent invasive disease.MedDRA version: 14.1Level: SOCClassification code 10021881Term: Infections and infestationsSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 14.1Level: LLTClassification code 10027276Term: Meningococcal meningitisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2011-000476-34-ITOVARTIS VACCINES AND DIAGNOSTICS S.R.L.800
已完成
4 期
Phase IV study, randomized, placebo-controlled for the evaluation of efficacy and tolerability of arginine aspartate in patients with moderate to severe fatigueModerate to severe fatigueOther - Conditions of unknown or disputed aetiology (such as chronic fatigue syndrome/myalgic encephalomyelitis)ACTRN12608000535370ikkho Zydus60
已完成
4 期
Parenting Eating and Activity for Child HealthChild overweightDiet and Nutrition - Other diet and nutrition disordersACTRN12606000120572Flinders University168